Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serial Dose of Alacramyn in Scorpionism
NCT06333834Phase 3Completed
- Start
- Jun 2024
- Primary completion
- Nov 2025
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of Scorpion Antivenom in scorpion envenomation. Started Jun 2024; status: completed.
02
Drugs
Scorpion Antivenom
03
Conditions
scorpion envenomation
Beyond the preview
Go deeper on NCT06333834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06333834.